PetVivo receives $3M from partial exercise of Series B convertible preferred stock purchase option

PetVivo Holdings, Inc.

Received $3,000,000 from partial exercise of Purchase Option; total proceeds to date $4,000,000 out of $5,000,000 offering.
Remaining $1,000,000 expected by June 26, 2025; shares priced at $1.00 each, convertible 1:1 to common stock.
Proceeds to fund commercialization of Spryng™ and PrecisePRP, clinical trials, and working capital.

item 1.01item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.